RxDoctor Payments Data

Linda Jones

Family · Mullins, SCNPI 1043284383

Payments from drug & device makers

$4,550in general payments, 2019–2025

Across 292 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$514
  • Boehringer Ingelheim$435
  • Lilly USA, LLC$391
  • AstraZeneca$376
  • Novo Nordisk$289
  • Pfizer$282
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$4,45098%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,550 in reported general payments places this provider in the 90th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin53$42,000
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,739
EliquisApixaban16$13,711
Breo ElliptaFluticasone/Vilanterol24$9,425
LinzessLinaclotide11$8,293
Rosuvastatin Calcium132$1,491
Celecoxib12$1,368
Ezetimibe34$1,317
Atorvastatin Calcium125$1,299
Albuterol Sulfate HfaAlbuterol Sulfate33$1,154
Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril34$996
Pantoprazole Sodium49$819
Amlodipine Besylate169$732
Pravastatin Sodium62$622
Ultra-Fine Short Pen NeedlePen Needle, Diabetic11$604

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$435$42,00053 claims
GSKTrelegy Ellipta, Breo Ellipta$161$24,16341 claims
PfizerEliquis$282$13,71116 claims
AbbVieLinzess$514$8,29311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,248 family providers in South Carolina.

Other family in Mullins

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →